1. Home
  2. ACET vs PED Comparison

ACET vs PED Comparison

Compare ACET & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$0.50

Market Cap

93.5M

Sector

Health Care

ML Signal

HOLD

Logo Pedevco Corp.

PED

Pedevco Corp.

SELL

Current Price

$0.54

Market Cap

54.4M

Sector

Energy

ML Signal

SELL

Company Overview

Basic Information
Metric
ACET
PED
Founded
1947
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
93.5M
54.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACET
PED
Price
$0.50
$0.54
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$8.50
$1.50
AVG Volume (30 Days)
2.3M
169.0K
Earning Date
11-05-2025
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
156.43
EPS
N/A
0.11
Revenue
N/A
$33,244,999.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$305.89
P/E Ratio
N/A
$5.14
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$0.43
52 Week High
$1.11
$1.00

Technical Indicators

Market Signals
Indicator
ACET
PED
Relative Strength Index (RSI) 33.08 48.57
Support Level $0.50 $0.55
Resistance Level $0.59 $0.61
Average True Range (ATR) 0.05 0.04
MACD 0.00 0.01
Stochastic Oscillator 4.20 61.10

Price Performance

Historical Comparison
ACET
PED

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.

Share on Social Networks: